Home > Financial Ratios > BLISS GVS PHARMA

BLISS GVS PHARMA
Working Capital/Sales

    Back to All Ratios
BLISS GVS PHARMA is part of below Screeners ↓
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for BLISS GVS PHARMA
Please provide your vote to see the results

BLISS GVS PHARMA Last 5 Year Working Capital/Sales History

[Consolidated]

Mar2023Mar2022Mar2021Mar2020Mar2019
   Working Capital/Sales(x) 1.491.371.031.281.85

What is the latest Working Capital/Sales ratio of BLISS GVS PHARMA ?

The latest Working Capital/Sales ratio of BLISS GVS PHARMA is 1.49 based on Mar2023 Consolidated results.
Year Working Capital/Sales
Mar20231.49
Mar20221.37
Mar20211.03
Mar20201.28
Mar20191.85

How is Working Capital/Sales of BLISS GVS PHARMA Trending?

Years Working Capital/Sales % Change
Mar2023 1.49
8.76
Mar2022 1.37
33.01
Mar2021 1.03
-19.53
Mar2020 1.28
-30.81
Mar2019 1.85 -

Other Financial Ratios of BLISS GVS PHARMA


Compare Working Capital/Sales ratio of peers of BLISS GVS PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BLISS GVS PHARMA ₹1,295.1 Cr 7% 8.4% 63.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹360,452.0 Cr 1.1% -6.6% 56.7% Stock Analytics
CIPLA ₹113,132.0 Cr 0.2% -4.4% 54.3% Stock Analytics
DIVIS LABORATORIES ₹106,191.0 Cr 4.8% 18.9% 23.9% Stock Analytics
DR REDDYS LABORATORIES ₹103,512.0 Cr 4.3% 2.6% 29.9% Stock Analytics
ZYDUS LIFESCIENCES ₹95,954.5 Cr 2.2% -4.6% 86.6% Stock Analytics


BLISS GVS PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BLISS GVS PHARMA

7%

8.4%

63.2%

SENSEX

1%

2.8%

23.9%


You may also like the below Video Courses